Interpace Biosciences, Inc. (IDXG)
OTCMKTS · Delayed Price · Currency is USD
5.11
-0.04 (-0.78%)
Oct 19, 2026, 2:10 PM EST
Interpace Biosciences Market Cap
Interpace Biosciences has a market cap or net worth of $28.32 million as of October 19, 2026. It is the 34,432nd most valuable company in the world and the 5,020th biggest in the United States. Its market cap has increased by 588.80% in one year.
Market Cap
28.32M
Enterprise Value
26.61M
Revenue
36.14M
Global Rank
Country Rank
#5,020 United States
PE Ratio
1.14
ChartMarket Cap Chart
Since May 20, 1998, Interpace Biosciences's market cap has decreased from 221.97M to 28.32M, a decrease of -87.24%. That is a compound annual growth rate of -6.99%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 19, 2026 | 28.32M | 419.81% |
| Dec 31, 2025 | 5.45M | -54.11% |
| Dec 31, 2024 | 11.87M | 152.98% |
| Dec 29, 2023 | 4.69M | 5.76% |
| Dec 30, 2022 | 4.44M | -85.77% |
| Dec 31, 2021 | 31.18M | 145.72% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Global Cord Blood | 127.35M |
| Bioqual | 29.52M |
| Longduoduo Company | 15.31M |
| Psychemedics | 15.25M |
| Aspira Women's Health | 10.54M |
| Stella Diagnostics | 3.02M |
| iMD Companies | 2.54M |
| IDenta | 1.53M |